About Us

Home  >  About Us  >  Company Overview

Tetra Bio-Pharma is a multi subsidiary publicly traded company (CSE:TBP, OTCQB:TBPMF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies.

Bringing REAL Science to Pharmaceutical Cannabis

1. Research and Markets has just released a forecast predicting that globally the medical marijuana market for the treatment of chronic pain, cancer, arthritis and migraines, will reach US$55.8 billion by 2025.